Evaluation of albumin microspheres as oral delivery system for Mycobacterium tuberculosis vaccines

References

• Adwell FE, Tucker IG, de Liste GW, Buddle BM. Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice. Infect Immun 2003; 71: 101–108
   PubMed Web of Science ®Google Scholar
• Ahsan F, Rivas IP, Khan MA, Torres Suarez AI. Targeting to macrophages: Role of physicochemical properties of particulate carriers-liposomes and microspheres—on the phagocytosis of microspheres. J Contr Rel 2002; 79: 29–40
   PubMed Web of Science ®Google Scholar
• Bachmann MF, Odermatt B, Hengartner H, Zinkernagel RM. Induction of long-lived germinal centers associated with persisting antigen after viral infection. J Exp Med 1996; 183: 2259–2269
   PubMed Web of Science ®Google Scholar
• Barrow EL, Winchester GA, Staas JK, Quenelle DC, Barrow WW. Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophages. Antimicrob Agents Chemother 1998; 42: 2682–2689
   PubMed Web of Science ®Google Scholar
• Belyakov IM, Moss B, Strober W, Berzofsky JA. Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity. Proc Natl Acad Sci USA 1999; 96: 4512–4517
   PubMed Web of Science ®Google Scholar
• Bodmeier R, McGinity JW. Solvent selection in the preparation of poly(D,L-lactide) microspheres prepared by the solvent evaporation method. Int J Pharm 1988; 43: 179–186
   Web of Science ®Google Scholar
• Brandt L, Feino Cunha J, Weinreich Olsen A, Chilima B, Hirsch P, Appelberg R, Andersen P. Failure of the Mycobacterium bovis BCG vaccine: Some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 2002; 70: 672–678
   PubMed Web of Science ®Google Scholar
• Challacombe SJ, Rahman D, O’Hagan DT. Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles. Vaccine 1997; 15: 169–175
   PubMed Web of Science ®Google Scholar
• Cleland JL, Lim A, Barron L, Duenas ET, Powell MF. Development of a single-shot subunit vaccine for HIV-1: part 4. Optimising microencapsulation and pulsatile release of MN rgp 120 from biodegradable microspheres. J Contr Rel 1997; 47: 135–150
   Web of Science ®Google Scholar
• Cleland JL, Powell MF, Shire SJ. Development of stable protein formulations: A close look at protein aggregation, deamidation, and oxidation. Crit Rev Ther Drug Carrier Syst 1993; 10: 307–377
   PubMed Web of Science ®Google Scholar
• Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, Fineberg HV. The efficacy of Baccillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: Meta-analyses of the published literature. Pediatrics 1995; 96: 29–35
   PubMed Web of Science ®Google Scholar
• Dietrich J, Weldingh K, Andersen P. Prospects for a novel vaccine against tuberculosis. Vet Microbiol 2006; 112: 163–169
   PubMed Web of Science ®Google Scholar
• Eldridge JH, Hammond CJ, Meulbroek JA, Staas JK, Gilley RM, Tice TR. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J Contr Rel 1990; 11: 205–214
   Web of Science ®Google Scholar
• Eldridge JH, Staas JK, Meulbroek JA, McGhee JR, Tice TR, Gilley RM. Biodegradable microspheres as a vaccine delivery system. Molec Immunol 1991; 28: 287–294
   PubMed Web of Science ®Google Scholar
• Feng CG, Palendira U, Demangel C, Spratt JM, Malin AS, Britton WJ. Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis. Infect Immun 2001; 69: 4174–4176
   PubMed Web of Science ®Google Scholar
• Galindo-Rodriquez SA, Allemann E, Fessi H, Doelker E. Polymeric nanoparticles for oral delivery of drugs and vaccines: A critical evaluation of in vivo studies. Crit Rev Ther Drug Carrier Syst 2005; 22: 419–463
   PubMed Web of Science ®Google Scholar
• Gallichan WS, Rosenthal KL. Long-lived cytotoxic T-Lymphocyte memory in mucosal tissues after mucosal but not systemic immunization. J Exp Med 1996; 184: 1879–1890
   PubMed Web of Science ®Google Scholar
• Gander B, Johansen P, Nam-Tran H, Merkle HP. Thermodynamic approach to protein microencapsulation into poly(D,L-lactide) by spray drying. Int J Pharm 1996; 129: 51–61
   Web of Science ®Google Scholar
• Garapin A, Ma L, Pescher P, Lagranderie M, Marchal G. Mixed immune response induced in rodents by two naked DNA genes coding for mycobacterial glycosylated proteins. Vaccine 2001; 19: 2830–2841
   PubMed Web of Science ®Google Scholar
• Gardner C, Acharya T, Pablos-Mendez A. The global alliance for tuberculosis drug development—accomplishments and future directions. Clin Chest Med 2005; 26(2)341–347
   PubMed Web of Science ®Google Scholar
• Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci 1961; 50: 874–875
   PubMed Web of Science ®Google Scholar
• Kaufmann SH. How can immunology contribute to the control of tuberculosis?. Natl Rev Immunol 2001; 1: 20–30
   PubMed Web of Science ®Google Scholar
• Kundig TM, Bachmann MF, Obashi PS, Pircher H, Hengartner H, Zinkernagel RM. On T cell memory: arguments for antigen dependence. Immunol Rev 1996; 150: 63–90
   PubMed Web of Science ®Google Scholar
• Lowrie DB, Silva CL, Colston MJ, Ragno S, Tascon RE. Protection against tuberculosis by a plasmid DNA vaccine. Vaccine 1997; 15: 834–838
   PubMed Web of Science ®Google Scholar
• Lowrie DB, Tascon RE, Bonato VL, Lima VM, Faccioli LH, Stavropoulos E. Therapy of tuberculosis in mice by DNA vaccination. Nature 1999; 400: 269–271
   PubMed Web of Science ®Google Scholar
• Maloy KJ, Donachie AM, O’Hagan DT, Mowat AM. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Immunology 1994; 81: 661–667
   PubMed Web of Science ®Google Scholar
• McShane H, Brookes R, Gilbert SC, Hill AV. Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis. Infect Immun 2001; 69: 681–686
   PubMed Web of Science ®Google Scholar
• Moingeon P, Almond J, de Wlde M. Therapeutic vaccines against infectious diseases. Curr Opin Microbiol 2003; 6: 462–471
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, McGee JP, Holmgren J, Mowat AM, Donachie AM, Mills KHG. Biodegradable microparticles for oral immunization. Vaccine 1993; 11: 149–154
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, Rahman D, Jeffery H, Sharif S, Challacombe SJ. Controlled release microparticles for oral immunization. Int J Pharm 1994; 108: 133–139
   Web of Science ®Google Scholar
• Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Contr Rel 2003; 90: 261–280
   PubMed Web of Science ®Google Scholar
• Skinner MA, Buddle BM, Wedlock DN, Keen D, de Lisle GW, Tascon RE. A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis. Infect Immun 2003; 71: 4901–4907
   PubMed Web of Science ®Google Scholar
• Tamber H, Johansen P, Merkle HP, Gander B. Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev 2005; 57: 357–376
   PubMed Web of Science ®Google Scholar
• Tanghe A, D'Souza S, Rosseels V, Denis O, Ottenhoff TH, Dalemans W. Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect Immun 2001; 69: 3041–3047
   PubMed Web of Science ®Google Scholar
• Tascon RE, Colston MJ, Ragno S, Stavropoulos E, Gregory D, Lowrie DB. Vaccination against tuberculosis by DNA injection. Nat Med 1996; 2: 888–892
   PubMed Web of Science ®Google Scholar
• Thakkar H, Sharma RK, Mishra AK, Chuttani K, Murthy RR. Albumin microspheres as carriers for the antiarthritic drug celecoxib. AAPS PharmSciTech 2005; 6: E65–E73
   PubMed Web of Science ®Google Scholar
• Thomasin C, Corradin G, Men Y, Merkle HP, Gander B. Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres: Importance of polymer degradation and antigen release for immune response. J Contr Rel 1996; 41: 131–145
   Web of Science ®Google Scholar
• Vordermeier HM, Rhodes SG, Dean G, Goonetilleke N, Huygen K, Hill AV. Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin. Immunology 2004; 112: 461–470
   PubMed Web of Science ®Google Scholar
• Wallis RS, Palaci M, Vinbas S, Hise AG, Ribeiro FC, Landen K, Chon S, Song H, Phillips M, Dietze R, et al. A whole blood bactericidal assay for tuberculosis. J Infect Dis 2001; 183: 300–303
   Web of Science ®Google Scholar
• Welsh RM, Selin LK, Szomolanyi-Tsuda E. Immunological memory to viral infections 1. Annl Rev Immunol 2004; 22: 711–743
   PubMed Web of Science ®Google Scholar
• Woodland DL. Jump-starting the immune system: prime-boosting comes of age. Trends Immunol 2004; 25: 98–104
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). 2004, Global tuberculosis control: WHO/HTM/TB/2004.331
   Google Scholar
• Zinkernagel RM, Ehl S, Aichele P, Oehen S, Kundig T, Hengartner H. Antigen localization regulates immune responses in a dose- and time-dependent fashion: a geographical review of immune reactivity. Immunol Rev 1997; 156: 199–209
   PubMed Web of Science ®Google Scholar
• Zinkernagel RM. On natural and artificial vaccinations. Annl Rev lmmunol 2003; 21: 515–546
   PubMed Web of Science ®Google Scholar